Yezan M. Haddadin
Independent DirectorMr. Yezan M. Haddadin is Chief Executive Officer since July 2017 and also serves as its Board of Directors of GMS Capital Partners LLC. Mr. Haddadin has been Director of Outlook Therapeutics, Inc. since April 13, 2018. He is Director of Pharma Nobis, LLC since February 02, 2022. Mr. Haddadin was a Director of Outlook Therapeutics, Inc. from October 31, 2017 until March 23, 2018. He leads direct private equity investment platform of GMS Holdings. Mr. Haddadin joined GMS Holdings in 2017. He leads direct private equity investment platform focused on non-MENA markets, with an emphasis on North America. Since July 2017. Mr. Haddadin has over few years of investment banking and private equity experience. He has extensive experience across a range of industries and has advised in M&A transactions in North America, Latin America, Europe, the Middle East and Africa. Prior to joining GMS Holdings, he was the Chief Executive Officer and Board Member of a regional investment bank based in Amman and Dubai from 2014 to 2017; Advisor at Ripplewood Holdings LLC, from 2013 to 2014; Managing Director at Perella Weinberg Partners in New York from 2007 to 2013 and an Executive Director in JPMorgan’s M&A Group in New York from 2000 to 2007. He is a Member of the Board of Directors at Sixth of October Investment Company (SODIC). He is also a Member of the Board of Directors of Jordan Ahli Bank. Mr. Haddadin is designated to the Board by GMS Ventures & Investments, or GMS Ventures, pursuant to the Amended and Restated Investor Rights Agreement by and between Outlook Therapeutics, Inc. and GMS Ventures dated April 21, 2022. He is a Fellow of the sixth class of the Middle East Leadership Initiative and a Member of the Aspen Global Leadership Network. Previously, he was a Board Member of The Near East Foundation. Mr. Haddadin previously served as a member of the board of directors at Sixth of October Development & Investment Company, a publicly listed Egyptian real estate development company. He holds a Juris Doctor in Law from Northwestern University School of Law from 1997 to 2000 and a Bachelor of Science in Foreign Service in Economics and Finance from Georgetown’s School of Foreign Service from 1992 to 1996. He is admitted to the New York State Bar Association and is FAA licensed pilot.
Positions
- Company NameOutlook Therapeutics, Inc.Stock CodeOTLKPositionIndependent DirectorColleagues
- RCRobert Charles JahrPresident, CEO & Director
- FGFaisal G. SukhtianIndependent Chairman of the Board
- KLKevin LundquistCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- JPJoel PrieveSenior Vice President of Licensing and M&A
- SSSurendra SharmaSenior Vice President of Medical Affairs
- JMJennifer M. KissnerSenior Vice President of Clinical Development & Regulatory Affairs
- KJKurt J. HilzingerIndependent Director
- RHRalph H. ThurmanLead Independent Director
